Establishing an appropriate sales price for a new technology has become one of the most difficult tasks facing a manufacturer. The price has to balance the need for an attractive return for the company while accommodating adequate profit for providers under a myriad of reimbursement systems, all the while avoiding backlash from consumers, the press and insurers.

More than ever before, technology prices are expected to be connected to the 'value' that the technology brings to the clinical arena. And evidence that the technology price is linked to its value is often used as justification for the price.

Strategic Health Resources uses its specialized expertise to develop evidence-based pricing models. These models target the price range a manufacturer can charge in consideration of the clinical and operational value the products will generate. These models are not only essential decision-support tools for manufacturers, but also function as presentation models for potential customers.